Australia's most trusted
source of pharma news
Friday, 17 October 2025
Friday, 17 October 2025
Subscribe
Login
Bitter $672M buyout is back on
An ugly court dispute over the sale of this Aussie pharma, which saw its US suitor try to back out of the deal, has ended in triumph for the locals.
Global shake-up spares Aussie jobs
ICYMI: Another global pharma unveils a new operating model and with it, job losses plus the other most popular stories this week
TODAY Your Week in 5 Minutes
PBAC backs historic funding model
Breakthrough in the way medicines are funded in Australia with a broad listing recommended for advanced or metastatic cancers
TODAY
Pharma sued over 'fake' Q&A
Two Australian pharmas are embroiled in a legal dispute over a reply to a question during a webinar
TODAY
69 blockbusters face patent cliff
Watch this space: pharmas brace for an historic loss of exclusivity on hundreds of drugs in the near future
16 October
Another global pharma cuts jobs
Worldwide downsizing of pharma continues with more jobs to go but in good news the Australian team won't be impacted
15 October
Who's won a Country Leader role?
Long time Sydney exec lands his first country leadership role for Novartis. Find out who it is and where
15 October
Latest Jobs
Finance Business PartnerLogistics SpecialistKey Account ManagerGP Sales Representative - Brisbane North - Flexible 3 Days - AstraZenecaMedical DirectorAssociate Brand ManagerGP Sales RepresentativeQCE Scientist Instrumentation (GDIP)27 more...
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (15)
- Key Account Manager - Melbourne
- GP Sales Representative - Brisbane North - Flexible 3 Days - AstraZeneca - Brisbane
- GP Sales Representative - Sydney
- Customer Service Representative - St Leonards
- Key Account Manager - Renal Metabolic - Adelaide - AstraZeneca - Adelaide, SA
- GP Sales Representative - Adelaide South - AstraZeneca - Adelaide, SA
- GP Sales Representative - Bundaberg, QLD - AstraZeneca - Bundaber, QLD
- Territory Manager - Melbourne
- Customer Service Representative - Macquarie Park
- Inside Sales - Sydney
- Customer Service Representative - Warriewood
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Belrose
- GP Sales Representatives - Melbourne - Southeaster Suburbs, Eastern Suburbs and Mornington Peninsula - AstraZeneca - VIC
- GP Sales Representative - Brisbane Western Suburbs- AstraZeneca - Brisbane
Clinical & Medical, R&D (6)
- Medical Director - Sydney
- QCE Scientist Instrumentation (GDIP) - Broadmeadows
- Medical Advisor - Sydney
- Medical Advisor - Sydney
- Clinical Specialist - Sydney
- Medical Science Liaison - Sydney
Regulatory, Pharmacovigilance & QA (1)
Executive Roles (1)
Other (12)
- Finance Business Partner - Surry Hills
- Logistics Specialist - Macquarie Park
- Senior Recruitment Consultant - Victoria
- Financial Analyst - Melbourne
- Senior Recruitment Consultant - Sydney
- Warehouse Assistant - Macquarie Park
- Financial Reporting Manager - Macquarie Park
- Warehouse Assistant & Forklift Driver - Lane Cove
- Senior Recruitment Consultant - Sydney
- Head of Human Resources, Supply & Manufacturing - Maternity Cover - AstraZeneca - Sydney, NSW
- People and Culture Manager - Kingsgrove
- Customer Operations Specialist - 4am Start - Macquarie Park
Obesity pill heading to the TGA
Race to be the first to bring an oral version of a blockbuster weight loss drug to Australia could be nearing an end
TODAY
Who's back... and who's leaving?
Company lures an Aussie expat home while another pharma farewells its first local employee in the latest job moves
TODAY
Next-in-class drug wins NZ nod
Medsafe has approved this soon-to-be blockbuster which analysts have pegged as one of the biggest drug launches this year
TODAY
Aussie manufacturing deal struck
New partnership agreement signed by two local companies has been hailed a win for Australia's advanced therapy capabilities
16 October
'Essential' drug finally hits TGA
This drug is considered essential by the World Health Organisation and was approved in the US and Europe five years ago
16 October
Novo walks away from cell therapy
Halts development of a potential 'cure' for type 1 diabetes with all 250 staff in the cell therapy division laid off
16 October
argenx inks Aussie drug partnership
First collaboration of its kind for argenx Australia to advance a pioneering molecule for autoimmune diseases
15 October
Ex-Pfizer exec snags top award
Ditching her 'ever present imposter syndrome', this Aussie ex-pharma exec-turned-CEO picks up a prestigious gong
15 October
Celeb fronts new GSK campaign
As new research findings pave the way for expanding the market for the company's blockbuster shingles vaccine
15 October
Middle managers: heroes or villians?
They've copped the brunt of downsizing across industry but experts warn they could actually be the drivers of performance
14 October
Lifeline lands for world's top drug
Top selling drug on the planet gets a makeover that could see it to continue earning billions for years to come
14 October
Blockbuster patent push teeters
Johnson & Johnson dealt a blow in attempts to maintain exclusivity over its blockbuster but it still has a couple of options to try
14 October
Rivals drop their swords... for now
In a rare alliance, the Pharmacy Guild and the Australian Medical Association have united for tighter controls over certain medicines
14 October
Novo eyes monster MASH market
Company digs deep for acquisition which includes a lead drug which has first and best in class potential to reverse liver damage
14 October